Richard Francis Wooster

Title: Richard Francis Wooster: Innovator in Cancer Research

Introduction

Richard Francis Wooster is a notable inventor based in Surrey, GB. He has made significant contributions to the field of cancer research, particularly in the identification and sequencing of the BRCA2 gene. His work has implications for understanding genetic predispositions to certain types of cancer, including breast and ovarian cancer.

Latest Patents

Wooster holds a patent related to materials and methods for the identification and sequencing of the BRCA2 gene. This patent discloses the amino acid sequence of the corresponding BRCA2 polypeptides. It also includes information on BRCA2 alleles, particularly those with mutations that are associated with a predisposition to develop cancer. The invention further relates to the uses of BRCA2 nucleic acid and polypeptides in diagnostic, prognostic, or therapeutic treatments for cancer. He has 1 patent to his name.

Career Highlights

Throughout his career, Wooster has worked with prestigious institutions, including Duke University and Cancer Research Campaign Technology Limited. His research has been pivotal in advancing the understanding of genetic factors in cancer.

Collaborations

Wooster has collaborated with notable colleagues in the field, including Phillip Andrew Futreal and Alan Ashworth. Their combined efforts have contributed to significant advancements in cancer research.

Conclusion

Richard Francis Wooster's innovative work in the identification and sequencing of the BRCA2 gene has made a lasting impact on cancer research. His contributions continue to influence diagnostic and therapeutic approaches in the fight against cancer.